deficiency arginine esterase cystic fibrosis pancreas demonstration proteolytic nature activity proteolytic activity defined hydrolysis peptide bond involving carboxyl group larginine plasma patient cystic fibrosis heterozygote control subject assayed using fluorometric method protamine substrate fluorescamine reagent mean total proteolytic activity plasma patient cystic fibrosis approximately onehalf mean total activity control subject heterozygote mean proteolytic activity inhibited soybean trypsin inhibitor plasma patient cystic fibrosis approximately onethird control subject heterozygote relationship arginine esterase activity proteolytic activity investigated ph optimum action reversible irreversible inhibitor similar activity suggesting arginine esterase activity proteolytic activity represent similar catalytic entity finding consistent hypothesis basic defect cystic fibrosis may reside deficiency proteolytic enzyme result accumulation various cationic macromolecular factor described investigator serum patient cystic fibrosis demonstration deficiency proteolytic activity assayed hydrolysis protamine cationic polypeptide could explain presence ciliotoxic cationic protein polypeptide factor serum patient cystic fibrosis may unknown manner related clinical manifestation disease